Drug intelligence / Profile preview

bethanecol + omeprazole

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intravenous, Subcutaneous
01

Overview

This is a combination of two pharmaceutical drugs, bethanechol and omeprazole. Bethanechol is a cholinergic agonist that stimulates muscarinic receptors, primarily used to treat urinary retention by increasing bladder muscle tone and promoting urination. It may also be used for certain gastrointestinal conditions such as gastroparesis or postoperative ileus due to its prokinetic effects[3][4][5]. Omeprazole is a proton pump inhibitor (PPI) that suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, commonly indicated for gastroesophageal reflux disease (GERD), peptic ulcer disease, and other acid-related disorders[6]. There are no known fixed-dose combination products containing both drugs; this entry refers to their concurrent use.

02

Targets

mAChR (Muscarinic acetylcholine receptors)ATP4A (Potassium–transporting ATPase alpha chain 1)

Beyond the preview

Go deeper on bethanecol + omeprazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bethanecol + omeprazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call